Literature DB >> 1557382

Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.

B I Gerwin1, E Spillare, K Forrester, T A Lehman, J Kispert, J A Welsh, A M Pfeifer, J F Lechner, S J Baker, B Vogelstein.   

Abstract

Loss of normal functions and gain of oncogenic functions when the p53 tumor suppressor gene is mutated are considered critical events in the development of the majority of human cancers. Human bronchial epithelial cells (BEAS-2B) provide an in vitro model system to study growth, differentiation, and neoplastic transformation of progenitor cells of lung carcinoma. When wild-type (WT) or mutant (MT; codon 143Val-Ala) human p53 cDNA was transfected into nontumorigenic BEAS-2B cells, we observed that (i) transfected WT p53 suppresses and MT p53 enhances the colony-forming efficiency of these cells, (ii) MT p53 increases resistance to transforming growth factor beta 1, and (iii) clones of MT p53 transfected BEAS-2B cells are tumorigenic when inoculated into athymic nude mice. These results are consistent with the hypothesis that certain mutations in p53 may function in multistage lung carcinogenesis by reducing the responsiveness of bronchial epithelial cells to negative growth factors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557382      PMCID: PMC48742          DOI: 10.1073/pnas.89.7.2759

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

Review 1.  TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

Authors:  H L Moses; E Y Yang; J A Pietenpol
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

2.  The p53 proto-oncogene can act as a suppressor of transformation.

Authors:  C A Finlay; P W Hinds; A J Levine
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

3.  Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells.

Authors:  H W Stürzbecher; P Chumakov; W J Welch; J R Jenkins
Journal:  Oncogene       Date:  1987-05       Impact factor: 9.867

4.  Cell density governs the ability of human bronchial epithelial cells to recognize serum and transforming growth factor beta-1 as squamous differentiation-inducing agents.

Authors:  Y Ke; B I Gerwin; S E Ruskie; A M Pfeifer; C C Harris; J F Lechner
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

5.  Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen.

Authors:  J R Jenkins; P Chumakov; C Addison; H W Stürzbecher; A Wade-Evans
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Transforming growth factor-beta and retinoic acid modulate phenotypic transformation of normal rat kidney cells induced by epidermal growth factor and platelet-derived growth factor.

Authors:  E J van Zoelen; T M van Oostwaard; S W de Laat
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

7.  Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.

Authors:  P W Hinds; C A Finlay; R S Quartin; S J Baker; E R Fearon; B Vogelstein; A J Levine
Journal:  Cell Growth Differ       Date:  1990-12

8.  Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.

Authors:  D Reisman; M Greenberg; V Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Authors:  T Masui; L M Wakefield; J F Lechner; M A LaVeck; M B Sporn; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  DNA binding properties of murine p53.

Authors:  K Steinmeyer; W Deppert
Journal:  Oncogene       Date:  1988-11       Impact factor: 9.867

View more
  34 in total

1.  Transforming growth factor β1 (TGF-β1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53.

Authors:  Gang Chen; Paritosh Ghosh; Thomas O'Farrell; Rachel Munk; Louis J Rezanka; Carl Y Sasaki; Dan L Longo
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

2.  Development of keratoacanthomas and squamous cell carcinomas in transgenic rabbits with targeted expression of EJras oncogene in epidermis.

Authors:  X Peng; J W Griffith; R Han; C M Lang; J W Kreider
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

3.  Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells.

Authors:  Xiangming Ji; Zhiwei Wang; Andreea Geamanu; Arvind Goja; Fazlul H Sarkar; Smiti V Gupta
Journal:  Int J Cancer       Date:  2012-06-26       Impact factor: 7.396

4.  Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.

Authors:  Eyal Kalo; Yosef Buganim; Keren E Shapira; Hilla Besserglick; Naomi Goldfinger; Lilach Weisz; Perry Stambolsky; Yoav I Henis; Varda Rotter
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

5.  Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.

Authors:  R Darley; A Morris; J Passas; W Bateman
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

6.  A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.

Authors:  J M Slingerland; L Hengst; C H Pan; D Alexander; M R Stampfer; S I Reed
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

7.  Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait.

Authors:  M Reiss; T Muñoz-Antonia; J M Cowan; P C Wilkins; Z L Zhou; V F Vellucci
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Comparison of gene expression profiles in chromate transformed BEAS-2B cells.

Authors:  Hong Sun; Harriet A Clancy; Thomas Kluz; Jiri Zavadil; Max Costa
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

9.  Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma.

Authors:  Y Sun; K Nakamura; E Wendel; N Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.

Authors:  B I Dalal; P A Keown; A H Greenberg
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.